Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Reduction in Transplantation Activity without Impairment in Outcomes in the Covid-19 Era- Data from the Sarah Cannon Blood Cancer Network (SCBCN)

Minoo Battiwalla, MD, Carlos Bachier, MD, Vikas Bhushan, MD, Michael J. Eckrich, MD MPH, Alireza Eghtedar, MD, Haydar Frangoul, MD, Suman Kambhampati, MD, Shahbaz Malik, MD, Peter A. McSweeney, MD, Jeremy Pantin, MBBS, Aravind Ramakrishnan, MD, Hana Safah, MD, Paul J Shaughnessy, MD, Betsy Blunk, BSN, RN, BMTCN, Tonya Cox, BSN, RN, Rocky Billups, MS, Charles F. Lemaistre, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-139121

Published: 2020

Journal Articles

Costs and Adverse Events Associated with Ibrutinib or Ruxolitinib in Chronic Graft-Versus-Host Disease

Carlos Bachier, MD, David Eiznhamer, PhD, Andrew Milgroom, MS, Mara Lenco, MS, Nayan Patel, MS, Jeffrey Rolf Skaar, PhD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-137756

Published: 2020

Journal Articles

Outcomes of Treatment with the Chimeric Antigen Receptor (CAR) T Cell Therapy Lisocabtagene Maraleucel (liso-cel) in the Nonuniversity Setting: Initial Results from the Outreach Study

John E. Godwin, MD, Cesar O. Freytes, MD, Michael Maris, MD, Don A. Stevens, MD, Daanish Hoda, MD, Bassam Mattar, MD, Juan C. Varela, MDPhD, Mohamad Cherry, MDMS, James Essell, MD, Jay Courtright, MD, Suzanne R. Fanning, DO, Habte A. Yimer, MD, Nikolaus S. Trede, MD PhD, Marina Youssef, PharmD, James Lymp, PhD, Carlos Bachier, MD

Blood (2020) 136 (Supplement 1): 50–52.

https://doi.org/10.1182/blood-2020-136640

Published: 2020

Journal Articles

A Phase 1 Study of NKX101, an Allogeneic CAR Natural Killer (NK) Cell Therapy, in Subjects with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-Risk Myelodysplastic Syndrome (MDS)

Carlos Bachier, MD, Gautam Borthakur, MD, Chitra Hosing, MD, William Blum, MD, Marcello Rotta, MD, Paulius Ojeras, Brian Barnett, MD, Kanya Rajangam, MD PhD, Navneet S. Majhail, MD MS, Sarah Nikiforow, MD PhD

Blood (2020) 136 (Supplement 1): 42–43.

https://doi.org/10.1182/blood-2020-134625

Published: 2020

Journal Articles

Outcomes of Autologous Transplants for Patients with Multiple Myeloma and Concurrent Multiple Plasmacytomas

Seema Naik, MD, Paul J. Shaughnessy, MD, Behyar Zoghi, MDPhD, Jose C Cruz, MD, Carlos Bachier, MD

Blood (2015) 126 (23): 1973.

https://doi.org/10.1182/blood.V126.23.1973.1973

Published: 2015

Journal Articles

The VIP (Very Immunocompromised Patient) Protocol: Improved Access To Care and Time To Antibiotics

Paul J. Shaughnessy, MD, Ann Kelley, RN, Roberta Tremper, RN, Jonathan Tinker, Carlos Bachier, MD, Joseph Holahan, MD, Roger M. Lyons, MD, Charles F. LeMaistre, MD

Blood (2013) 122 (21): 2978.

https://doi.org/10.1182/blood.V122.21.2978.2978

Published: 2013

Journal Articles

High Correlation of Pre-Apheresis Peripheral Blood CD34+ Cell Counts with Final Apheresis Product CD34+ Cell Count by Using a More Accurate Determination of Patient Blood Volume

Brandon Parker, James Hastings, Jill Folkert, RN, Gayla Nagy, RN, Carlos Bachier, MD, Charles F. LeMaistre, MD, Paul Shaughnessy, MD

Blood (2011) 118 (21): 2996.

https://doi.org/10.1182/blood.V118.21.2996.2996

Published: 2011

Journal Articles

Mismatches in Ethnicity Between Donor and Recipient Affects Overall Survival In Umbilical Cord Blood Transplantation,

Patali Shikhi Cheruku, Veronica H. Jude, MD, Renee M Madden, MD, Charles F. LeMaistre, MD, Ka Wah Chan, MD, MBBS, Paul Shaughnessy, MD, Carlos Bachier, MD

Blood (2011) 118 (21): 4159.

https://doi.org/10.1182/blood.V118.21.4159.4159

Published: 2011

Journal Articles

Prophylaxis of Acute Gvhd Using Stromal Cell Therapy: Preliminary Results After Administration of Single or Multiple Doses of Multistem® in a Phase I Trial

Richard T. Maziarz, MD, Timothy deVos, M.D., Carlos Bachier, MD, Steven C. Goldstein, MD, Jose F. Leis, MD, PhD, Robert Perry, B.S., Robert Deans, PhD, Wouter J Van't Hof, PhD, Hillard M. Lazarus, MD

Blood (2011) 118 (21): 1987.

https://doi.org/10.1182/blood.V118.21.1987.1987

Published: 2011

Journal Articles

Seizures During Infusion of Autologous Peripheral Blood Stem Cells Are Related to High White Blood Cell Concentration in the Peripheral Blood Stem Cell Product and Can Be Prevented by Dilution of Product with Autologous Plasma

Carlos Bachier, MD, Grant Potter, Joshua Potter, Charles F. LeMaistre, MD, Paul Shaughnessy, MD, Kawah Chan, MD, Veronica H. Jude, MD, Renee Madden

Blood (2011) 118 (21): 4386.

https://doi.org/10.1182/blood.V118.21.4386.4386

Published: 2011

Journal Articles

Upfront Tandem Autologous Stem Cell Transplant Is Superior to Autologous or Allogeneic Stem Cell Transplant After Failure of a 1st Autologous Transplant,

Adrian Wong, MD, Charles F. LeMaistre, MD, Paul Shaughnessy, MD, Carlos Bachier, MD

Blood (2011) 118 (21): 4094.

https://doi.org/10.1182/blood.V118.21.4094.4094

Published: 2011

Journal Articles

Oral Loading of Tacrolimus and Sub-Therapeutic Levels on the Day of Transplant Do Not Predict the Incidence of Acute Graft Versus Disease or Survival After Allogeneic Stem Cell Transplant

Jill MacPherson, FNP-BC, AOCNP, Carlos Bachier, MD, Charles F. LeMaistre, MD, Hannah Sowell, RN, Luis Garcia, RN, Alessandra Curel-Sanchez, RN, Wilma Cain, RN, Ursula Caga, RN, Jeremy Means, RN, Paul Shaughnessy, MD

Blood (2011) 118 (21): 4543.

https://doi.org/10.1182/blood.V118.21.4543.4543

Published: 2011

Journal Articles

Collection of Autologous Peripheral Blood Stem Cells Using the COBE Spectra Is Associated with Higher CD34+ Yields and Requires Less Collection Time Than the Fresenius AS104 Cell Separator.

Grant W Potter, Charles F. LeMaistre, MD, Paul Shaughnessy, MD, Miguel Islas, MD, Juan Huerta, Carlos Bachier, MD

Blood (2009) 114 (22): 2158.

https://doi.org/10.1182/blood.V114.22.2158.2158

Published: 2009

Journal Articles

Clinical and Cost Outcomes of Double Umbilical Cord Blood Versus Bone Marrow and Peripheral Blood Unrelated Hematopoietic Stem Cell Transplants.

Guillermo López-González, Charles F. LeMaistre, MD, Carlos Bachier, MD, Brad Smith, PhD, Ka Wah Chan, MBBS, Michael Grimley, MD, Wilma Cain, Elina Delgado, Shawn Kaleel, Paul Shaughnessy, MD

Blood (2008) 112 (11): 967.

https://doi.org/10.1182/blood.V112.11.967.967

Published: 2008

Journal Articles

Once Daily Busulfan and Fludarabine Is Well Tolerated and Effective in Older Heavily Treated Patients Prior to Unrelated Donor Allogeneic Peripheral Blood Stem Cell Transplant.

Grant W. Potter, Carlos Bachier, MD, Brad Smith, PhD, Maureen Hougham, C.F. LeMaistre, MD, Paul J. Shaughnessy, MD

Blood (2007) 110 (11): 4950.

https://doi.org/10.1182/blood.V110.11.4950.4950

Published: 2007

Journal Articles

Once Daily Busulfan Cyclophosphamide Is Well Tolerated and Effective Prior to Allogeneic Hematopoietic Stem Cell Transplantation.

Julia A. LeMaistre, Carlos Bachier, MD, Brad Smith, PhD, C.F. LeMaistre, MD, Paul J. Shaughnessy, MD

Blood (2007) 110 (11): 1996.

https://doi.org/10.1182/blood.V110.11.1996.1996

Published: 2007

Journal Articles

Intravenous Busulfan Dosed Once Daily or Four Times Daily as Part of the Standard BuCy Preparative Regimen for Allogeneic Stem Cell Transplantation.

Paul J. Shaughnessy, MD, Carlos Bachier, MD, Lorraine Alexander, C. F. LeMaistre, MD

Blood (2005) 106 (11): 5327.

https://doi.org/10.1182/blood.V106.11.5327.5327

Published: 2005

Journal Articles

Comparison between G-CSF and GM-CSF for Mobilization of Dendritic Cells, CD34+ Cells, and CD3+ Cells in Normal Donors.

Paul J. Shaughnessy, MD, Carlos Bachier, MD, Al Nanez, BS, Cagla Akay, MD, C. F. LeMaistre, MD, Yair Gazitt, PhD

Blood (2004) 104 (11): 2870.

https://doi.org/10.1182/blood.V104.11.2870.2870

Published: 2004

Journal Articles

Valganciclovir for the Early Prophylaxis of Cytomegalovirus (CMV) Infection after Allogeneic Stem Cell Transplantation.

Carlos Bachier, MD, Paul Shaughnessy, MD, Donna Wall, MD, Michael Grimley, MD, George Carrum, MD, Cesar Freytes, MD, Natalie Callander, MD, Tracey Walsh, PharmD, C. Fred LeMaistre, MD

Blood (2004) 104 (11): 5074.

https://doi.org/10.1182/blood.V104.11.5074.5074

Published: 2004

Journal Articles

Efficacy of Fluconazole Prophylaxis for Autologous Peripheral Blood Stem Cell Transplantation: Results of a Prospective, Randomized, Controlled, Multicenter, Open Label Study.

Tracey L. Walsh, PharmD, Carlos Bachier, MD, Paul Shaughnessy, MD, Cesar O. Freytes, MD, Natalie Callander, MD, C. Fred LeMaistre, MD, Michael Grimley, MD, Patrick Bradshaw, MS

Blood (2004) 104 (11): 5096.

https://doi.org/10.1182/blood.V104.11.5096.5096

Published: 2004

NARROW

Reduction in Transplantation Activity without Impairment in Outcomes in the Covid-19 Era- Data from the Sarah Cannon Blood Cancer Network (SCBCN)

Costs and Adverse Events Associated with Ibrutinib or Ruxolitinib in Chronic Graft-Versus-Host Disease

Outcomes of Treatment with the Chimeric Antigen Receptor (CAR) T Cell Therapy Lisocabtagene Maraleucel (liso-cel) in the Nonuniversity Setting: Initial Results from the Outreach Study

A Phase 1 Study of NKX101, an Allogeneic CAR Natural Killer (NK) Cell Therapy, in Subjects with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-Risk Myelodysplastic Syndrome (MDS)

Outcomes of Autologous Transplants for Patients with Multiple Myeloma and Concurrent Multiple Plasmacytomas

The VIP (Very Immunocompromised Patient) Protocol: Improved Access To Care and Time To Antibiotics

High Correlation of Pre-Apheresis Peripheral Blood CD34+ Cell Counts with Final Apheresis Product CD34+ Cell Count by Using a More Accurate Determination of Patient Blood Volume

Mismatches in Ethnicity Between Donor and Recipient Affects Overall Survival In Umbilical Cord Blood Transplantation,

Prophylaxis of Acute Gvhd Using Stromal Cell Therapy: Preliminary Results After Administration of Single or Multiple Doses of Multistem® in a Phase I Trial

Seizures During Infusion of Autologous Peripheral Blood Stem Cells Are Related to High White Blood Cell Concentration in the Peripheral Blood Stem Cell Product and Can Be Prevented by Dilution of Product with Autologous Plasma

Upfront Tandem Autologous Stem Cell Transplant Is Superior to Autologous or Allogeneic Stem Cell Transplant After Failure of a 1st Autologous Transplant,

Oral Loading of Tacrolimus and Sub-Therapeutic Levels on the Day of Transplant Do Not Predict the Incidence of Acute Graft Versus Disease or Survival After Allogeneic Stem Cell Transplant

Collection of Autologous Peripheral Blood Stem Cells Using the COBE Spectra Is Associated with Higher CD34+ Yields and Requires Less Collection Time Than the Fresenius AS104 Cell Separator.

Clinical and Cost Outcomes of Double Umbilical Cord Blood Versus Bone Marrow and Peripheral Blood Unrelated Hematopoietic Stem Cell Transplants.

Once Daily Busulfan and Fludarabine Is Well Tolerated and Effective in Older Heavily Treated Patients Prior to Unrelated Donor Allogeneic Peripheral Blood Stem Cell Transplant.

Once Daily Busulfan Cyclophosphamide Is Well Tolerated and Effective Prior to Allogeneic Hematopoietic Stem Cell Transplantation.

Intravenous Busulfan Dosed Once Daily or Four Times Daily as Part of the Standard BuCy Preparative Regimen for Allogeneic Stem Cell Transplantation.

Comparison between G-CSF and GM-CSF for Mobilization of Dendritic Cells, CD34+ Cells, and CD3+ Cells in Normal Donors.

Valganciclovir for the Early Prophylaxis of Cytomegalovirus (CMV) Infection after Allogeneic Stem Cell Transplantation.

Efficacy of Fluconazole Prophylaxis for Autologous Peripheral Blood Stem Cell Transplantation: Results of a Prospective, Randomized, Controlled, Multicenter, Open Label Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only